Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Meldex International has announced its intention to launch two new OTC medicines, Phytosulin and DAOsin, in Europe during the first half of 2008.
Subscribe to our email newsletter
While Phytosulin is for people who may be resistant to insulin, DAOsin is for the treatment of histamine intolerance, an under-estimated and under-diagnosed condition which can lead to gastro-intestinal and circulation problems, migraine, asthma and allergy-like symptoms.
Richard Trevillion, CEO of Meldex, said: “These products have the potential to significantly improve the health and quality of life of many people. Their launches next year are in line with the company’s strategy of exploiting its newly established critical mass in valuable and growing markets.”